title: Role of complement in the aetiology of Pick's disease?
abstract: Complement in the postmortem brains of 15 cases of Pick's disease has been widely analyzed immunohistochemically and, in 2 cases, by immunoelectron microscopy. Astrocytes and the Pick bodies and cytoplasm of ballooned neurons were immunoreactive with antibodies to classical pathway components C1, C1q, C4, C2 and C3 and the terminal complex components C5, C6 and C8. In almost all cases, no immunostaining was obtained with antibodies against C9 and neoepitopes in the membrane attack complex (MAC), the complement complex responsible for cytotoxicity. However, unequivocal staining with antibodies to two soluble complement regulatory proteins, S-protein and clusterin, and to the membrane complement inhibitor CD59 was found, although three other membrane inhibitors, CR1(CD35), DAF (CD55), and MCP (CD46), were not detected. The complement immunoreactivity of astrocytes and neurons could be the result of complement biosynthesis or attack. Complement attack will be restricted by the expressed regulatory proteins. However, neurons may be the victims of attack since they show pathological change. The internalization of complement-attacked membrane, perhaps involving the genesis of Pick bodies and ballooning, may explain the intracellular immunolocalization of complement in damaged neurons. Immunoglobulins, as a possible source of complement activation, were observed in only two cases, leaving unresolved the trigger for complement activation in the other cases.
authors.affiliation: Medical Electron Microscopy Unit, University of Wales College of Medicine, Health Park, Cardiff, UK.
authors.forename: S K
authors.initials: SK
authors.lastname: Singhrao
authors.forename: J W
authors.initials: JW
authors.lastname: Neal
authors.forename: P
authors.initials: P
authors.lastname: Gasque
authors.forename: B P
authors.initials: BP
authors.lastname: Morgan
authors.forename: G R
authors.initials: GR
authors.lastname: Newman
mesh_terms: D000368:Aged; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001253:Astrocytes / Q000737:chemistry; D051152:Clusterin; D003171:Complement Pathway, Classical; D003165:Complement System Proteins / Q000032:analysis*; D003704:Dementia / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D002479:Inclusion Bodies / Q000737:chemistry; D008297:Male; D051379:Mice; D017628:Microglia / Q000737:chemistry; D008854:Microscopy, Electron; D008875:Middle Aged; D018832:Molecular Chaperones; D009419:Nerve Tissue Proteins / Q000032:analysis* / Q000276:immunology; D009474:Neurons / Q000737:chemistry; D011817:Rabbits; D009418:S100 Proteins / Q000032:analysis; D013702:Temporal Lobe / Q000737:chemistry; D016875:tau Proteins / Q000032:analysis
chemical_list: D000911:Antibodies, Monoclonal; C495242:CLU protein, human; C495243:Clu protein, mouse; D051152:Clusterin; D006023:Glycoproteins; D018832:Molecular Chaperones; D009419:Nerve Tissue Proteins; D009418:S100 Proteins; D016875:tau Proteins; D003165:Complement System Proteins